Persistence of neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection

Clinical Infectious Diseases

Volumn 60, Issue 4, 2015, Pages 557-563

  Bissessor, Melanie ^a,b   Whiley, David M ^c,d   Fairley, Christopher K ^a,e   Bradshaw, Catriona S ^a,e   Lee, David M ^a   Snow, Anthony S ^a   Lahra, Monica M ^f,g   Hocking, Jane S ^b   Chen, Marcus Y ^a,e  

^a MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e MONASH UNIVERSITY   (Australia)

^f PRINCE OF WALES HOSPITAL   (Australia)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

gonorrhea; minimum inhibitory concentration of antibiotics; persistent DNA on NAAT testing; reinfection; test of cure

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFTRIAXONE; DNA; OPA PROTEIN, NEISSERIA; OUTER MEMBRANE PROTEIN; PORIN; PORIN PROTEIN, NEISSERIA;

ADULT; BACTERIAL LOAD; GENETICS; GONORRHEA; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION; PHARYNGEAL DISEASES; PHARYNX; REAL TIME POLYMERASE CHAIN REACTION; RECTAL DISEASES; RECTUM; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTERIAL LOAD; BACTERIAL OUTER MEMBRANE PROTEINS; CEFTRIAXONE; DNA; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PHARYNGEAL DISEASES; PHARYNX; PORINS; REAL-TIME POLYMERASE CHAIN REACTION; RECTAL DISEASES; RECTUM; YOUNG ADULT;

EID: 84922381203     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu873     Document Type: Article

References (37)

1. World Health Organization/United Nations Children's Fund. Global HIV/AIDS response: epidemic update and health sector progress towards universal access. Progress report November 2011. Available at: http://www.who.int/hiv/pub/progress-report2011/en/index.html. Accessed 10 March 2014.
2. Morris SR, Klausner JD, Buchbinder SP, et al. Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study. Clin Infect Dis 2006; 43:1284-9.
3. Weinstock H, Workowski KA. Pharyngeal gonorrhea: an important reservoir of infection?. Clin Infect Dis 2009; 49:1798-800.
4. Goire N, Lahra MM, Chen M, et al. Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance. Nat Rev Microbiol 2014; 12:223-9.
5. Bignell C, Fitzgerald M. UK national guideline for the management of gonorrhoea in adults. Int J STD AIDS 2011; 22:541-7.
6. Unemo M, Nicholas RA. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol 2013; 7:1401-22.
7. Ohnishi M, Watanabe Y, Ono E, et al. Spread of a chromosomal cefixime-resistant penA gene among different Neisseria gonorrhoeae lineages. Antimicrob Agents Chemother 2009; 54:1060-7.
8. Bernstein KT, Marcus JL, Nieri G, Philip SS, Klausner JD. Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr 2010; 53:537-43.
9. Jin F, Prestage GP, Mao L, et al. Incidence and risk factors for urethral and anal gonorrhoea and chlamydia in a cohort of HIV-negative homosexual men: the Health in Men Study. Sex Transm Infect 2007; 83: 113-9.
10. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. 2010. MMWR Recomm Rep 2010; 59(RR-12):1-110.
11. Sexually transmitted infection testing guidelines for men who have sex with men 2010. Available at: http://www.stigma.net.au/resources/STIGMA-MSM-Testing-Guidelines-2010.pdf. Accessed 11 February 2014.
12. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae-2014. MMWR Recomm Rep 2014; 63(RR-02): 1-19.
13. Schachter J, Moncada J, Liska S, Shayevich C, Klausner JD. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 2008; 35:637-42.
14. Bolan GA, Sparling PF, Wasserheit JN. The emerging threat of untreatable gonococcal infection. N Engl J Med 2012; 366:485-7.
15. Chisholm SA, Mouton JW, Lewis DA, et al. Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?. J Antimicrob Chemother 2010; 65:2141-8.
16. Katz AR, Komeya AY, Soge OO, et al. Neisseria gonorrhoeae with highlevel resistance to azithromycin: case report of the first isolate identified in the United States. Clin Infect Dis 2012; 54:841-3.
17. Ohnishi M, Saika T, Hoshina S, et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis 2011; 17:148-9.
18. Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2011; 56: 1273-80.
19. Chen MY, Stevens K, Tideman R, et al. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia. J Antimicrob Chemother 2013; 68:1445-7.
20. Read PJ, Limnios EA, McNulty A, Whiley D, Lahra MM. One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500 mg ceftriaxone in Sydney, Australia. Sex Health 2013; 10:460-2.
21. World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva, Switzerland: WHO, 2012.
22. Bachmann LH, Desmond RA, Stephens J, Hughes A, Hook EW 3rd. Duration of persistence of gonococcal DNA detected by ligase chain reaction in men and women following recommended therapy for uncomplicated gonorrhea. J Clin Microbiol 2002; 40:3596-601.
23. Hjelmevoll SO, Olsen ME, Sollid JU, et al. Appropriate time for test-ofcure when diagnosing gonorrhoea with a nucleic acid amplification test. Acta Derm Venereol 2012; 92:316-9.
24. Dicker LW, Mosure DJ, Steece R, Stone KM. Laboratory tests used in US public health laboratories for sexually transmitted diseases, 2000. Sex Transm Dis 2004; 31:259-64.
25. Low N, Unemo M, Skov Jensen J, Breuer J, Stephenson JM. Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea. PLoS Med 2014; 11:e1001598.
26. Razali MF, Fairley CK, Hocking J, Bradshaw CS, Chen MY. Sampling technique and detection rates for pharyngeal gonorrhea using culture. Sex Transm Dis 2010; 37:522-4.
27. Mitchell M, Rane V, Fairley CK, et al. Sampling technique is important for optimal isolation of pharyngeal gonorrhoea. Sex Transm Infect 2013; 89:557-60.
28. Tapsall J; Members of the National Neisseria Network of Australia. Antimicrobial testing and applications in the pathogenic Neisseria. In: Merlino J, ed. Antimicrobial susceptibility testing: methods and practices with an Australian perspective. Sydney: Australian Society for Microbiology, 2004; 175-88.
29. Goire N, Nissen MD, LeCornec GM, Sloots TP, Whiley DM. A duplex Neisseria gonorrhoeae real-time polymerase chain reaction assay targeting the gonococcal porA pseudogene and multicopy opa genes. Diagn Microbiol Infect Dis 2008; 61:6-12.
30. Tabrizi SN, Chen S, Tapsall J, Garland SM. Evaluation of opa-based real-time PCR for detection of Neisseria gonorrhoeae. Sex Transm Dis 2005; 32:199-202.
31. Whiley DM, Sloots TP. Comparison of three in-house multiplex PCR assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis using real-time and conventional detection methodologies. Pathology 2005; 37:364-70.
32. Whiley DM, Goire N, Ray ES, et al. Neisseria gonorrhoeae multi-Antigen sequence typing using non-cultured clinical specimens. Sex Transm Infect 2010; 86:51-5.
33. Yuan CC, Miley W, Waters D. A quantification of human cells using an ERV-3 real time PCR assay. J Virol Methods 2001; 91: 109-17.
34. Alsaleh AN, Whiley DM, Bialasiewicz S, et al. Nasal swab samples and real-time polymerase chain reaction assays in community-based, longitudinal studies of respiratory viruses: the importance of sample integrity and quality control. BMC Infect Dis 2014; 14:15-7.
35. Page-Shafer K, Graves A, Kent C, Balls JE, Zapitz VM, Klausner JD. Increased sensitivity of DNA amplification testing for the detection of pharyngeal gonorrhea in men who have sex with men. Clin Infect Dis 2002; 34:173-6.
36. Bissessor M, Tabrizi SN, Fairley CK, et al. Differing Neisseria gonorrhoeae bacterial loads in the pharynx and rectum in men who have sex with men: implications for gonococcal detection, transmission and control. J Clin Microbiol 2011; 49:4304-6.
37. Blumer JL, Reed MD, Kaplan EL, Drusano GL. Explaining the poor bacteriologic eradication rate of single-dose ceftriaxone in group a streptococcal tonsillopharyngitis: a reverse engineering solution using pharmacodynamic modeling. Pediatrics 2005; 116:927-32.